£92.69

This is the most expensive it has ever been. Walk away.

£93 today · previous high £93 · all-time low £92

Elsevier Brain Metastases from Primary Tumors, Volume 3: Epidemiology, Biology, and Therapy of Melanoma and Other Cancers

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 53 days · 53 data points (no recent data)

Historical
Generating forecast…
£92.69 £92.32 £92.40 £92.48 £92.56 £92.64 £92.72 27 July 2026 09 August 2026 22 August 2026 04 September 2026 17 September 2026
View at Amazon ↗

Price data last checked 38 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 53 days • 1 price levels

Days at Price
53 days 0 13 27 40 53 £92 Days at Price

Price Analysis

Most common price: £92 (53 days, 100.0%)

Price range: £92 - £92

Price levels: 1 different prices over 53 days

Description

Brain Metastases from Primary Tumors Volume Three: Epidemiology, Biology, and Therapy of Melanoma and Other Cancers provides a comprehensive overview of the metastasis of cancer, the main cause of approximately 90% of cancer associated deaths, yet the mechanisms governing this clinically important process remain poorly understood. Melanoma is the third most common diagnosis among patients with brain metastases, after lung and breast cancer. Approximately 75% of patients with metastatic melanoma develop brain metastases during the course of their disease. Although tumorigenesis of melanoma remains poorly understood, recent advances in gene expression profiling have revealed molecular mechanisms of this deadly disease. In addition, high-throughput gene expression has many advantages over techniques in cancer transcriptomic studies and has led to the discovery of numerous diagnostic, prognostic, and therapeutic targets, which are also detailed in this book. The book discusses the link between primary tumors and brain metastasis of melanoma, including molecular mechanisms, treatment options, prognosis, and general applications. Comprehensive chapters discuss systemic therapy, integrin inhibitors, stereotaxic radiosurgery, and more, making this book a great resource for neurooncologists, neurosurgeons, neurologists, and cancer researchers. Presents the only comprehensive reference detailing the link between primary cancers and brain metastases in melanoma Aids the target audience in discussing various treatment options for patients with brain metastases from melanoma Edited work with chapters authored by leaders in the field around the globe – the broadest, most expert coverage available

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
08 June 2016
Listed Since
04 February 2016

Barcode

No barcode data available

Similar Products You Might Like

Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy: 1
97% match

Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy: 1

Elsevier

£117.95 01 Oct 2026
Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6
96% match

Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6

Springer

£203.36 20 Aug 2026
Methods of Cancer Diagnosis, Therapy, and Prognosis: Brain Cancer: 8
96% match

Methods of Cancer Diagnosis, Therapy, and Prognosis: Brain Cancer: 8

Springer

£148.21 06 Oct 2026
Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy: 2
96% match

Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy: 2

Elsevier

£91.26 18 Sep 2026
Brain Metastases: 136 (Cancer Treatment and Research, 136)
96% match

Brain Metastases: 136 (Cancer Treatment and Research, 136)

Springer

£42.40 12 Aug 2026
Glioma: Immunotherapeutic Approaches: 746 (Advances in Experimental Medicine and Biology, 746)
96% match

Glioma: Immunotherapeutic Approaches: 746 (Advances in Experimental Medicine and Biology, 746)

Springer

£80.67 01 Oct 2026
Molecular Pathology of Nervous System Tumors - Springer Medical Guide
95% match

Molecular Pathology of Nervous System Tumors - Springer Medical Guide

Springer

£99.56 17 Sep 2026
Cutaneous Melanoma and Precursor Lesions: 25 (Developments in Oncology, 25)
95% match

Cutaneous Melanoma and Precursor Lesions: 25 (Developments in Oncology, 25)

Springer

£159.06 06 Oct 2026
Brain Metastases: 136 (Cancer Treatment and Research, 136)
95% match

Brain Metastases: 136 (Cancer Treatment and Research, 136)

Springer

£80.64 11 Sep 2026
Late Effects of Treatment for Brain Tumors: 150 (Cancer Treatment and Research, 150)
95% match

Late Effects of Treatment for Brain Tumors: 150 (Cancer Treatment and Research, 150)

Springer

£120.59 17 Sep 2026
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)
95% match

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)

Elsevier

£119.00 23 Sep 2026
MELANOMA MOLECULAR BIOLOGY: Molecular Biology, Risk Factors & Treatment Options (Cancer Etiology, Diagnosis and Treatments: Dermatology - Laboratory and Clincal Research)
95% match

MELANOMA MOLECULAR BIOLOGY: Molecular Biology, Risk Factors & Treatment Options (Cancer Etiology, Diagnosis and Treatments: Dermatology - Laboratory and Clincal Research)

£85.32 24 Sep 2026
Cutaneous Melanoma and Precursor Lesions: 25 (Developments in Oncology)
95% match

Cutaneous Melanoma and Precursor Lesions: 25 (Developments in Oncology)

Springer

£158.29 11 Sep 2026
Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
95% match

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

Springer

£117.56 15 Aug 2026
Combined Modality Therapy of CNS Tumors - Medical Radiology
95% match

Combined Modality Therapy of CNS Tumors - Medical Radiology

Springer

£124.48 05 Oct 2026
Tumors of the Central Nervous system, Volume 3: Brain Tumors (Part 1)
95% match

Tumors of the Central Nervous system, Volume 3: Brain Tumors (Part 1)

Springer

£149.00 02 Oct 2026
Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma (Current Clinical Pathology)
95% match

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma (Current Clinical Pathology)

Humana

£156.39 22 Aug 2026
Melanoma: 167 (Cancer Treatment and Research, 167)
95% match

Melanoma: 167 (Cancer Treatment and Research, 167)

Springer

£113.76 02 Oct 2026
Brain Cancer Therapy and Surgical Interventions (Horizons in Cancer Research)
95% match

Brain Cancer Therapy and Surgical Interventions (Horizons in Cancer Research)

£114.14 19 Sep 2026
Brain Metastases Advanced Neuroimaging - Springer Medical
95% match

Brain Metastases Advanced Neuroimaging - Springer Medical

Springer

£111.39 15 Oct 2026
Elsevier Neuro-Oncology for the Clinical Neurologist Book
95% match

Elsevier Neuro-Oncology for the Clinical Neurologist Book

Elsevier

£78.29 22 Aug 2026
Molecular Diagnostics for Melanoma: Methods and Protocols: 1102 (Methods in Molecular Biology, 1102)
95% match

Molecular Diagnostics for Melanoma: Methods and Protocols: 1102 (Methods in Molecular Biology, 1102)

Humana

£141.67 15 Aug 2026
BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery: 82 (Cancer Drug Discovery and Development, 82)
95% match

BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery: 82 (Cancer Drug Discovery and Development, 82)

Humana

£75.63 18 Sep 2026
Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy
95% match

Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy

Springer

£113.09 26 Sep 2026